Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 471 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups
Patents for C07D 471 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups (64,559)
05/2000
05/17/2000EP1000030A1 Piperidine oligomers and combinatorial libraries thereof
05/17/2000EP1000026A1 Special 3-azabicyclo 3.1.0]hexanes, method for producing and modifying the same, and their use
05/17/2000EP1000012A1 Process for converting propargylic amine-n-oxides to enaminones
05/17/2000EP0869959B1 1,7-disubstituted perylene-3,4,9,10-tetracarboxylic acids and dianhydrides and diimides of said acids
05/17/2000CN1253528A Optical recording media
05/17/2000CN1253502A Method of using cyclooxygenase-2 inhibitors in prevention of cardiovascular disorders
05/17/2000CN1052482C Camptothecin derivatives, preparations thereof and antitumor agents
05/16/2000US6063924 N-(alkenyl or alkynyl)oxycarbonyl substituted chromophore derivatives; soluble organic pigments
05/16/2000US6063908 Reagents for lysergic acid diethylamide immunoassay
05/16/2000US6063847 Thrombin receptor antagonists
05/16/2000US6063181 1,7-disubstituted perylene-3,4,9, 10-tetracarboxylic acids, their dianhydrides and diimides of said acids
05/16/2000CA2289363A1 Pesticidal and parasiticidal use of 2-(substituted thio) thiazolo-[4,5-b] pyridine compounds
05/16/2000CA2180263C Diazabicyclic neurokinin antagonists
05/16/2000CA2126752C Benzopyran and related ltb4 antagonists
05/16/2000CA2011658C New 1,7-annelated 1h-indole-2-carboxylic acid-n-(1,4-benzodiazepin-3-yl) amides
05/11/2000WO2000026217A1 Imidazonaphthyridines
05/11/2000WO2000026216A1 Pyrazolopyridine derivatives as selective cox-2 inhibitors
05/11/2000WO2000026211A1 Thrombin inhibitors
05/11/2000WO2000026210A1 Thrombin inhibitors
05/11/2000WO2000026203A1 2-ureido-thiazole derivatives, process for their preparation, and their use as antitumor agents
05/11/2000WO2000026197A1 Novel inhibitors of impdh enzyme
05/11/2000WO2000026186A1 Pyrrolidine compounds and medicinal utilization thereof
05/11/2000CA2349567A1 Pyrazolopyridine derivatives as selective cox-2 inhibitors
05/11/2000CA2349476A1 Imidazonaphthyridines
05/11/2000CA2348879A1 Pyrrolidine compound and pharmaceutical use thereof
05/11/2000CA2348734A1 Thrombin inhibitors
05/11/2000CA2348530A1 Thrombin inhibitors
05/11/2000CA2348267A1 Novel inhibitors of impdh enzyme
05/11/2000CA2347060A1 2-ureido-thiazole derivatives, process for their preparation, and their use as antitumor agents
05/10/2000EP0999239A2 Heterocyclic compounds
05/10/2000EP0998928A1 Antitussives
05/10/2000EP0998674A2 Conjugate for differentiating between healthy and unhealthy tissue
05/10/2000CN1252802A Writable and eresable high-density optical storage media
05/10/2000CN1052233C Alkaloids from mappia foetida, the use and formulations containing them
05/10/2000CN1052232C Substituted oxazine derivatives
05/09/2000US6060601 Fluorescent dyes in highly sensitive detection methods, reagents for the qualitative, semiquantitative and quantitative detection
05/09/2000US6060482 Serotonin inhibitors
05/09/2000US6060480 Preventives/remedies for muscle tissue degenerations
05/09/2000US6060432 Synergistic mixture; crops, agriculture
05/04/2000WO2000024743A1 Pyrano, piperidino, and thiopyrano compounds and methods of use
05/04/2000WO2000024742A1 Pyrazolopyridine as adenosine antagonists
05/04/2000WO2000024741A2 Dihydropyridine compounds and their use as potassium channel openers
05/04/2000WO2000024717A2 Isoquinoline derivatives
05/04/2000WO2000006082A3 Treatment of anxiety disorders
05/04/2000WO1999064038A9 Novel analgesic agents
05/04/2000WO1999064031A9 β2-ADRENERGIC RECEPTOR AGONISTS
05/04/2000WO1999063988A9 Inhibitors of nitric oxide synthase
05/04/2000CA2348576A1 Pyrano, piperidino, and thiopyrano compounds and methods of use
05/04/2000CA2348165A1 Dihydropyridine compounds and methods of use
05/03/2000EP0997466A1 Novel antimicrobial lactam-quinolones
05/03/2000EP0997465A1 Azaindole derivatives and their use as antithrombotic agents
05/03/2000EP0997464A1 1,3,8-Triazaspiro[4,5] decanone compounds as orl1-receptor agonists
05/03/2000EP0997463A1 Naphthyridine derivatives
05/03/2000EP0997462A1 Novel naphthyridine derivatives or salts thereof
05/03/2000EP0997459A1 Intermediates for preparing retroviral protease inhibiting compounds
05/03/2000EP0996619A1 Tropane analogs and methods for inhibition of monoamine transport
05/03/2000EP0996439A1 $g(b)-ALKOXYACRYLATES AGAINST MALARIA
05/03/2000CN1252070A 5,7-disubstituted 4-aminopyrido [2,3,-d] pyrimidine compounds and their use as adenosine kinase inhibitors
05/03/2000CN1252069A 5,6,7-trisubstituted-4-aminopyrido [2,3-d] pyrimidine compounds
05/03/2000CN1052005C Imidazopyridines and preparation and use thereof as medicines
05/03/2000CN1052004C Heterocyclic compounds, their production and use
05/02/2000US6057445 Formation of carbon nitrogen bond, cyclization and halogenation
05/02/2000US6057371 Sigma receptor ligands and the use thereof
05/02/2000US6057340 Oxazole derivatives as serotonin-1A receptor agonists
05/02/2000US6057336 Lactam metalloprotease inhibitors
05/02/2000US6057333 Useful as immunomodulatory, antitumor agents, and/or caspase inhibitors
05/02/2000US6057329 Inhibitors of the protein tyrosine kinases and are of use in the prophylaxis and treatment of immune diseases, hyperproliferative disorders and other diseases
05/02/2000US6057325 Have central dopamine and serotonin antogonistic activity
05/02/2000US6057320 Bis mono-and bicyclic aryl and heteroaryl compounds which inhibit EGF and/or PDGF receptor tyrosine kinase
05/02/2000US6057313 Treating central nervous system disorders
05/02/2000US6057270 Herbicides
05/02/2000US6057120 Quantitative or qualitative detection of analyte by contacting sample with indicator and detecting change in property of reagent; reagent is stable in reduced and oxidized forms
05/02/2000CA2224616C Process for preparing derivatives of azabicyclo naphthyridine carboxylic acid comprising a dipeptide
04/2000
04/30/2000CA2288386A1 Antithrombotic agents
04/27/2000WO2000023487A1 Amino-ketone solid support templates
04/27/2000WO2000023451A1 New compounds, their preparation and use
04/27/2000WO2000023447A1 Adenosine analogues having antihypertensive, cardioprotective, anti-ischemic antilipolytic properties
04/27/2000WO2000023446A1 Core-extended perylene bisimides and the use thereof as fluorescent dyes
04/27/2000WO2000023445A1 New compounds, their preparation and use
04/27/2000WO2000023444A1 5,7-disubstituted-4-aminopyrido[2,3-d]pyrimidine compounds
04/27/2000WO2000023443A1 Tetrahydropyridopyridine derivatives and intermediates for producing the same
04/27/2000WO2000023433A1 Substituted benzopyran analogs for the treatment of inflammation
04/27/2000WO2000023425A1 New compounds, their preparation and use
04/27/2000WO2000023424A1 Epibatidine analogues as acetylcholine receptor antagonists
04/27/2000WO1999063933A9 Multivalent agonists, partial agonists and antagonists of the gaba receptors
04/27/2000DE19848555A1 New perylene-3,4,9,10-tetracarboxylic acid bis-imide derivatives and analogs, used as dyes, especially fluorescent dyes, e.g. for bulk dyeing plastics, vat dyeing natural fibers or staining DNA
04/27/2000CA2347910A1 Substituted benzopyran analogs for the treatment of inflammation
04/27/2000CA2347243A1 Amino-ketone solid support templates
04/26/2000EP0995748A1 Growth hormone secretagogues
04/26/2000EP0995743A1 Derivatives of dihydro- and tetrahydrochinoline as a medicinal antioxydans
04/26/2000EP0995742A1 Sulfonamide compounds and medicinal use thereof
04/26/2000EP0994881A1 Ortho-metalation process for the synthesis of 2-substituted-1-(tetrazol-5-yl)benzenes
04/26/2000EP0994877A1 Imidazopyrimidines and imidazopyridines for the treatment of neurological disorders
04/26/2000EP0994875A1 3-pyridyl-1-aza-bicyclo-alkane derivatives for prevention and treatment of cns disorders
04/26/2000EP0802913B1 IMIDAZO [4,5-c]QUINOLINE AMINES
04/26/2000EP0766963B1 Arteriosclerosis depressant
04/26/2000EP0738269B1 Piperidine derivatives with paf antagonist activity
04/26/2000EP0683780B1 Imidazopyridines and their use in treating gastrointestinal diseases
04/26/2000EP0680469B1 Aminoacid derivates, medicaments containing these compounds and process for preparing the same
04/26/2000EP0579802B1 Bicycle-polyazamacrocyclocarboxylic acid complexes, conjugates, preparation and use as contrast agents
1 ... 494 495 496 497 498 499 500 501 502 503 504 505 506 507 508 509 510 511 512 513 514 ... 646